Development of an auxotrophic oral live Shigella flexneri vaccine (Q39227963)

10 September 2017

1 reference

title

Development of an auxotrophic oral live Shigella flexneri vaccine (English)

1 reference

10 September 2017

1 reference

Lindberg AA

1 reference

10 September 2017

Kärnell A

1 reference

10 September 2017

Stocker BA

1 reference

10 September 2017

Katakura S

1 reference

10 September 2017

Sweiha H

1 reference

10 September 2017

Reinholt FP

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 April 1988

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

146-150

1 reference

Bacillary dysentery: mechanisms and treatment

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Pathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Interruption of shigellosis by hand washing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Shigella Infection of Henle Intestinal Epithelial Cells: Role of the Host Cell

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Multiplication of Shigella flexneri within HeLa cells: lysis of the phagocytic vacuole and plasmid-mediated contact hemolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Metabolic events mediating early killing of host cells infected by Shigella flexneri

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Experimental human bacillary dysentery; polyvalent dysentery vaccine in its prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Protection of Monkeys Against Experimental Shigellosis with Attenuated Vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Immunity in Shigellosis. I. Response of Man to Attenuated Strains of Shigella

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Studies with a New Generation of Oral Attenuated Shigella Vaccine: Escherichia coli Bearing Surface Antigens of Shigella flexneri

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

Auxotrophic Salmonella typhi as live vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2888%2980018-5

7 January 2021

10.1016/S0264-410X(88)80018-5

Identifiers

DOI

1 reference

release_2p2huzk7grglxekon63xcei7lq

10 September 2017

Fatcat ID

0 references

1 reference